Mirador Capital Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Hold |
4,000
| – | – | 0.07% | 153 |
|
|
2025
Q1 | $467K | Hold |
4,000
| – | – | 0.08% | 139 |
|
|
2024
Q4 | $338K | Hold |
4,000
| – | – | 0.06% | 151 |
|
|
2024
Q3 | $359K | Hold |
4,000
| – | – | 0.06% | 152 |
|
|
2024
Q2 | $322K | Hold |
4,000
| – | – | 0.06% | 149 |
|
|
2024
Q1 | $319K | Hold |
4,000
| – | – | 0.06% | 155 |
|
|
2023
Q4 | $318K | Hold |
4,000
| – | – | 0.07% | 146 |
|
|
2023
Q3 | $280K | Hold |
4,000
| – | – | 0.06% | 151 |
|
|
2023
Q2 | $287K | Hold |
4,000
| – | – | 0.07% | 161 |
|
|
2023
Q1 | $247K | Hold |
4,000
| – | – | 0.06% | 169 |
|
|
2022
Q4 | $309K | Buy |
+4,000
| New | +$309K | 0.07% | 148 |
|